Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
P K Honig
Observed names:
P HONIG,
P Honig,
Peter Honig
Observed institutions:
Merck & Co., Inc., Rahway, NJ, USA (United States),
Center for Drug Evaluation and Research
OpenAlex ID:
A5111809287
A Proposal for Integrated Efficacy-to-Effectiveness (E2E) Clinical Trials
2013
·
H P Selker
, K A Oye
, et al.
·
Clinical Pharmacology & Therapeutics
·
34
PDF
Pharmacometrics and the Transition to Model-Based Development
2007
·
T H Grasela
, C W Dement
, et al.
·
Clinical Pharmacology & Therapeutics
·
30
An Evaluation of Computer-Aided Disproportionality Analysis for Post-Marketing Signal Detection
2007
·
H P Lehman
, J Chen
, et al.
·
Clinical Pharmacology & Therapeutics
·
30
Recent Trends and Success Factors in Reducing the Lag Time to Approval of New Drugs in Japan
2014
·
P K Honig
·
Clinical Pharmacology & Therapeutics
·
28
Advancing the Science of Pharmacovigilance
2013
·
P K Honig
·
Clinical Pharmacology & Therapeutics
·
24
Comparative Effectiveness: The Fourth Hurdle in Drug Development and a Role for Clinical Pharmacology
2011
·
P K Honig
·
Clinical Pharmacology & Therapeutics
·
24
The value and future of clinical pharmacology
2007
·
P Honig
·
Clinical Pharmacology & Therapeutics
·
20
Benefit and Risk Assessment in Drug Development and Utilization: A Role for Clinical Pharmacology
2007
·
P Honig
·
Clinical Pharmacology & Therapeutics
·
16
Intelligent Pharmaceuticals: Beyond the Tipping Point
2014
·
P Honig
, S-M Huang
·
Clinical Pharmacology & Therapeutics
·
10
Affairs of the Heart: Innovation in Cardiovascular Research and Development
2017
·
P Honig
, A Terzic
·
Clinical Pharmacology & Therapeutics
·
9
Medicare and Cost-Effectiveness Analysis
2006
·
Marc Berger
, Peter Honig
, et al.
·
New England Journal of Medicine
·
5
Regulatory Science and the Role of the Regulator in Biomedical Innovation
2012
·
P K Honig
, S-M Huang
·
Clinical Pharmacology & Therapeutics
·
4
Reinventing Bioinnovation
2013
·
K I Kaitin
, P K Honig
·
Clinical Pharmacology & Therapeutics
·
3
Prevalence and Clinical Utility
2011
·
P K Honig
·
Clinical Pharmacology & Therapeutics
·
2
The Right Medicines—Just Not Enough of Them
2012
·
P K Honig
·
Clinical Pharmacology & Therapeutics
·
1
Merck Sharp and Dohme versus Laporte
2004
·
Peter Honig
·
The Lancet
·
1
PDF
Clinical pharmacology studies in patients with renal impairment (RI): Past experience and regulatory perspectives
1999
·
S IBRAHIM
, S HUANG
, et al.
·
Clinical Pharmacology & Therapeutics
Show more works
View as search
Works count:
17
Citation count:
241
H-index:
9
I10-index:
9
Year
Topic
Type